When Less is More: The Rising Tide of Hypofractionation.
作者信息
Aitken K, Mukherjee S
机构信息
Department of Radiotherapy, Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK.
Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.
出版信息
Clin Oncol (R Coll Radiol). 2022 May;34(5):277-279. doi: 10.1016/j.clon.2022.03.002. Epub 2022 Mar 16.
Abstract
摘要
相似文献
1
When Less is More: The Rising Tide of Hypofractionation.
Clin Oncol (R Coll Radiol). 2022 May;34(5):277-279. doi: 10.1016/j.clon.2022.03.002. Epub 2022 Mar 16.
2
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial.
Lancet Oncol. 2021 Feb;22(2):235-245. doi: 10.1016/S1470-2045(20)30581-7. Epub 2021 Jan 11.
3
Can Hypofractionation and Immune Modulation Coexist?
Int J Radiat Oncol Biol Phys. 2021 Jul 1;110(3):742-744. doi: 10.1016/j.ijrobp.2021.02.052.
4
[A story of hypofractionation and the "Table on the Wall"].
Strahlenther Onkol. 2022 Aug;198(8):759-760. doi: 10.1007/s00066-022-01947-w. Epub 2022 Jun 8.
5
A Story of Hypofractionation and the Table on the Wall.
Int J Radiat Oncol Biol Phys. 2022 Jan 1;112(1):4-21. doi: 10.1016/j.ijrobp.2021.09.027.
6
Does cost minimization of hypofractionated radiation therapy content all health stakeholders?
J Med Imaging Radiat Sci. 2023 Sep;54(3):405-409. doi: 10.1016/j.jmir.2023.05.042. Epub 2023 Jun 14.
7
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial.
Lancet. 2019 Aug 3;394(10196):385-395. doi: 10.1016/S0140-6736(19)31131-6. Epub 2019 Jun 18.
8
FLASH radiotherapy: Considerations for multibeam and hypofractionation dose delivery.
Radiother Oncol. 2021 Nov;164:122-127. doi: 10.1016/j.radonc.2021.09.011. Epub 2021 Sep 23.
9
Moderate hypofractionation for early laryngeal cancer improves local control.
Eur Arch Otorhinolaryngol. 2020 Oct;277(10):2943-2944. doi: 10.1007/s00405-020-06082-9. Epub 2020 May 30.
10
Hypofractionation for clinically localized prostate cancer.
Cochrane Database Syst Rev. 2019 Sep 3;9(9):CD011462. doi: 10.1002/14651858.CD011462.pub2.
引用本文的文献
1
Optimal Fractionation Scheduling for Radiotherapy Treatments with Reinforcement Learning, Tumor Growth Modeling and Outcome Modeling.
Biomedicines. 2025 Jun 3;13(6):1367. doi: 10.3390/biomedicines13061367.
2
Addressing challenges in low-income and middle-income countries through novel radiotherapy research opportunities.
Lancet Oncol. 2024 Jun;25(6):e270-e280. doi: 10.1016/S1470-2045(24)00038-X.
3
Optimizing Clinical Implementation of Hypofractionation: Comprehensive Evidence Synthesis and Practical Guidelines for Low- and Middle-Income Settings.
Cancers (Basel). 2024 Jan 26;16(3):539. doi: 10.3390/cancers16030539.
4
Use of focal radiotherapy boost for prostate cancer: radiation oncologists' perspectives and perceived barriers to implementation.
Radiat Oncol. 2023 Nov 11;18(1):188. doi: 10.1186/s13014-023-02375-5.
5
Geriatric Radiation Oncology: What We Know and What Can We Do Better?
Clin Interv Aging. 2023 May 4;18:689-711. doi: 10.2147/CIA.S365495. eCollection 2023.
本文引用的文献
1
From 25 Fractions to Five: How Hypofractionation has Revolutionised Adjuvant Breast Radiotherapy.
Clin Oncol (R Coll Radiol). 2022 May;34(5):332-339. doi: 10.1016/j.clon.2022.03.001. Epub 2022 Mar 19.
2
Hypofractionation in Hepatocellular Carcinoma - The Effect of Fractionation Size.
Clin Oncol (R Coll Radiol). 2022 May;34(5):e195-e209. doi: 10.1016/j.clon.2022.02.021. Epub 2022 Mar 18.
3
Technical Radiotherapy Advances - The Role of Magnetic Resonance Imaging-Guided Radiation in the Delivery of Hypofractionation.
Clin Oncol (R Coll Radiol). 2022 May;34(5):301-312. doi: 10.1016/j.clon.2022.02.020. Epub 2022 Mar 16.
4
UK 2022 Consensus on Normal Tissue Dose-Volume Constraints for Oligometastatic, Primary Lung and Hepatocellular Carcinoma Stereotactic Ablative Radiotherapy.
Clin Oncol (R Coll Radiol). 2022 May;34(5):288-300. doi: 10.1016/j.clon.2022.02.010. Epub 2022 Mar 7.
5
How Low Can You Go? The Radiobiology of Hypofractionation.
Clin Oncol (R Coll Radiol). 2022 May;34(5):280-287. doi: 10.1016/j.clon.2022.02.009. Epub 2022 Mar 5.
6
Hypofractionated Radiation Therapy in Keratinocyte Carcinoma.
Clin Oncol (R Coll Radiol). 2022 May;34(5):e218-e224. doi: 10.1016/j.clon.2022.02.016. Epub 2022 Mar 5.
7
The Changing Landscape for the Treatment of Painful Spinal Metastases: is Stereotactic Body Radiation Therapy the New Standard of Care?
Clin Oncol (R Coll Radiol). 2022 May;34(5):325-331. doi: 10.1016/j.clon.2022.02.005. Epub 2022 Mar 3.
8
Stereotactic Ablative Radiotherapy for Oligometastatic Disease: Great Enthusiasm but Scant Evidence.
Clin Oncol (R Coll Radiol). 2022 May;34(5):313-317. doi: 10.1016/j.clon.2022.02.008. Epub 2022 Feb 26.
9
Stereotactic Ablative Radiotherapy for Oligometastatic Disease: A Tale of Emperor's New Clothes or New Standard of Care?
Clin Oncol (R Coll Radiol). 2022 May;34(5):318-324. doi: 10.1016/j.clon.2022.02.006. Epub 2022 Feb 25.
10
Single-Fraction Stereotactic Ablative Body Radiotherapy to the Lung - The Knockout Punch.
Clin Oncol (R Coll Radiol). 2022 May;34(5):e183-e194. doi: 10.1016/j.clon.2022.02.004. Epub 2022 Feb 24.
Zotero 插件